OVF

Assay, Direct, Nucleic Acid Amplification, Q Fever

Product code
OVF
Device name
Assay, Direct, Nucleic Acid Amplification, Q Fever
Device class
Class 1
21 CFR
21 CFR 866.3500
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

These reagents are nucleic acid primers and probes intended for the amplification and identification of Coxiella burnetii directly from clinical specimens. The identification aids in the diagnosis of Q Fever and provides epidemiological information on this disease. This reagent differs from the description in the regulation in that it consists of nucleic acid primers and probes rather than antisera or antigens.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: OVF
Classification and pathway per current FDA publications. Data from openFDA (CC0).